House GOP Leadership Shake Up Could Benefit 340B Providers

Rep. Elise Stefanik (R-N.Y.), one of the 340B program’s most vocal advocates in the U.S. House, is expected to be elevated to the House GOP's No. 3 leadership post. | C-SPAN

There is a 340B angle in the fight in the U.S. House over who should be third in the Republican leadership ranks.

The GOP caucus is expected to vote tomorrow to remove Rep. Liz Cheney (R-Wyo.) as House Republican Conference

Read More »

Lilly Wants Judge To Schedule June Arguments in 340B Suit Against HHS

Drug maker Eli Lilly's motion yesterday in its 340B contract pharmacy lawsuit against HHS mainly covered the same ground as in its original January complaint. | Shutterstock

Drug manufacturer Eli Lilly yesterday asked a federal district judge in Indianapolis to schedule oral argument as soon as mid-June in its lawsuit challenging both a federal legal advisory opinion about 340B contract pharmacy and the 340B program’s new administrative

Read More »

North Dakota Is the Latest State to Pass a 340B Non-Discrimination Law

The North Dakota legislature (above) passed, and Gov. Doug Burgum (R) has signed, legislation prohibiting pharmacy benefit managers from discriminating against 340B covered entities or their contract pharmacies.

North Dakota Gov. Doug Burgum (R) has signed legislation prohibiting pharmacy benefit managers (PBMs) from discriminating against 340B covered entities or their contract pharmacies.

Burgum’s approval of H.B. 1492 on April 21 made North Dakota one of six states

Read More »
Industry Insights Logo

What Covered Entities Should Know About Contracting with Specialty Pharmacies

SPONSORED CONTENT

By: Diana Sierra, MPH, VP, Contract Pharmacy Partnership & RVS Operations, Sentry Data Systems

For years, covered entities generated savings from the 340B program largely by contracting with retail pharmacies. Brick-and-mortar storefronts in their local communities, many of them trailblazing independent pharmacies, provided the most benefit for covered entities in the

Read More »

340B Non-Discrimination Bills Signed in Arkansas and Indiana and Passed in Tennessee

Tennessee lawmakers this week passed a 340B non-discrimination bill, sending it to Gov. Bill Lee for his signature.

Arkansas’s and Indiana’s governors have signed bills in recent days to prevent pharmacy benefit managers (PBMs) from discriminating against 340B covered entities, and a similar bill is awaiting the Tennessee governor’s signature.

Arkansas Gov. Asa Hutchinson (R) signed his state’s

Read More »

Multiple Developments in AstraZeneca’s 340B Contract Pharmacy Lawsuit

There were a handful of significant developments this week AstraZeneca's lawsuit to derail an HHS advisory opinion on 340B contract pharmacy.

The plain language of the 340B statute “explicitly requires drug manufacturers to offer 340B discounts to 340B covered entities regardless of whether the drugs are dispensed by the entity or by an outside pharmacy with which the entity has a

Read More »

Bristol-Myers Squibb Hires Apexus VP Richardson to Be its 340B Strategist

Long time Apexus vice president Katheryne Richardson is Bristol-Myers Squibb's new 340B strategist.

Katheryne Richardson, a long time Apexus vice president who was instrumental in launching its 340B University educational program and Apexus Answers call center, is moving to Bristol-Myers Squibb (BMS) to become the drug manufacturer’s 340B program strategist.

Her move to

Read More »

Study: Better Use of 340B Can Help Shrink Urban “Pharmacy Deserts”

A new study in Health Affairs says there is a role for the 340B program for eliminating “pharmacy deserts” in Black and Hispanic/Latino urban neighborhoods. | Shutterstock

Policymakers should make better use of the 340B program to help eliminate “pharmacy deserts” in Black and Hispanic/Latino urban neighborhoods, new research published in Health Affairs recommends.

The study was conducted by researchers at four universities and supported by the

Read More »

Expect to Hear a Lot About Drug Pricing During Next Week’s House Hearing With Becerra

House E&C Chair Frank Pallone (D-N.J.), speaking remotely from his home, said during a hearing this week that he looks forward to enacting the House Democrats' drug pricing legislation, H.R. 3, this year.

A powerful U.S. House health subcommittee has invited U.S. health secretary Xavier Becerra to brief it next week about his department’s discretionary budget request for the coming fiscal year, and to discuss how they might collaborate on lowering drug prices

Read More »
Industry Insights Logo

Podcast: Dynamics of 340B Program Spotlight the Value of Strong Pharmacy-Finance Partnerships

SPONSORED CONTENT

The devastating double-whammy of Medicare Part B payment cuts and COVID-19 has again highlighted the 340B program’s significance to hospital finance. Once relegated to the hospital’s basement pharmacy, the 340B program is increasingly a topic of boardroom and C-suite discussions.

In the latest episode of Omnicell’s The Future of Pharmacy podcast, learn

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live